TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic

An estimated 90% of those with Major Depressive Disorder (MDD) report sleep related problems [1] and as many as 40% meet criteria for Insomnia Disorder [2]. MDD in the setting of Insomnia Disorder has been associated with more severe symptoms, increased risk of suicidal planning [3], as well as an increased risk of relapse when treated [4]. Residual insomnia symptoms may persist in as many as 72% of patients in remission from depression [5]. Repetitive Transcranial Magnetic Stimulation (rTMS) is an evidence-based treatment for MDD with proven efficacy and effectiveness [6].

Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - September 23, 2021 Category: Neurology Authors: Michael A. Norred, Lindsay Haselden, Gregory L. Sahlem, Allison K. Wilkerson, E. Baron Short, Lisa M. McTeague, Mark S. George Source Type: research